CLYM - Climb Bio, Inc. Common Stock -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
Climb Bio, Inc. Common Stock
IPO Date: August 10, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $615.14M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.29 | 4.80%
Avg Daily Range (30 D): $0.48 | 3.36%
Avg Daily Range (90 D): $0.50 | 3.68%
Institutional Daily Volume
Avg Daily Volume: .35M
Avg Daily Volume (30 D): 1.35M
Avg Daily Volume (90 D): 1.21M
Trade Size
Avg Trade Size (Sh.): 117
Avg Trade Size (Sh.) (30 D): 75
Avg Trade Size (Sh.) (90 D): 82
Institutional Trades
Total Institutional Trades: 258
Avg Institutional Trade: $1.84M
Avg Institutional Trade (30 D): $2.03M
Avg Institutional Trade (90 D): $2.02M
Avg Institutional Trade Volume: .22M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.6M
Avg Closing Trade (30 D): $2.8M
Avg Closing Trade (90 D): $2.6M
Avg Closing Volume: 243K
 
News
Apr 6, 2026 @ 5:00 PM
Idiopathic Membranous Nephropathy Market is Predic...
Source: Delveinsight
Feb 5, 2026 @ 12:00 PM
Climb Bio to Present at Upcoming Investor Conferen...
Source: Not Specified
Nov 25, 2025 @ 12:00 PM
Climb Bio Reports Inducement Grant Under Nasdaq Li...
Source: Carlo Tanzi, Ph.D.
Oct 17, 2025 @ 11:00 AM
Climb Bio to Present Data at American Society of N...
Source: Climb Bio, Inc.
Aug 25, 2025 @ 6:41 PM
UPDATE – Climb Bio to Present at Upcoming S...
Source: Carlo Tanzi, Ph.D.
Financials
  TTM Q1 2026 Q4 2025
Basic EPS $-.18 $-.2 $-.25
Diluted EPS $-.18 $-.2 $-.25
Revenue $M $M $M
Gross Profit
Net Income / Loss $-13.5M $-13.72M $-17.52M
Operating Income / Loss $-15.36M $-15.21M $-19.3M
Cost of Revenue
Net Cash Flow $85.72M $-27.33M $-51.54M
PE Ratio